Search results
Results from the WOW.Com Content Network
Organ trade (also known as the blood market or the red market) is the trading of human organs, tissues, or other body products, usually for transplantation. [1] [2] According to the World Health Organization (WHO), organ trade is a commercial transplantation where there is a profit, or transplantations that occur outside of national medical systems.
In contrast, a compatible kidney sold on the global black-market can cost in excess of $160,000 in some cases. [12] One payment option is the official contract, which gives the donor the US$1,219 (in 2001), and is paid immediately after the surgery. The kidney recipient may also negotiated with the donor by providing additional money or other ...
Organ theft is the act of taking a person's organs for transplantation or sale on the black market, without their explicit consent through means of being an organ donor or other forms of consent. Most cases of organ theft involve coercion, occurrences in wartime, or thefts within hospital settings. [ 1 ]
For premium support please call: 800-290-4726 more ways to reach us
In the illegal black market, the donors may not get sufficient after-operation care, [43] the price of a kidney may be above $160,000, [44] middlemen take most of the money, the operation is more dangerous to both the donor and receiver, and the buyer often gets hepatitis or HIV. [45] In legal markets of Iran the price of a kidney is $2,000 to ...
All 230 U.S. hospitals that do kidney transplants had until Jan. 4 to go back and recalculate waiting times for Black patients. 2,470 Black transplant patients get new kidney after medical redress ...
In 2010, the Transplant of Human Organs and Tissues Act criminalized buying and selling organs and allows only donation upon death in Egypt. [18] However, the law had minimal effects practically eliminating the organ black market. The profit that actors get through this lucrative business trumps the mild penalties assigned to legal violation. [4]
(Reuters) -Private equity firm Carlyle Group is in exclusive talks to acquire Baxter International's kidney care spinoff Vantive for more than $4 billion, including debt, a person familiar with ...